Oral glucosylceramide reduces 2,4-dinitrofluorobenzene induced inflammatory response in mice by reducing TNF-alpha levels and leukocyte infiltration.

Download in:

• JSON
• RDF
• N3/Turtle
• N-Triples

View as

• Triples